Page-5 of COVID-19 vaccine Current Affairs, GK & News

ZyCoV-D: World’s first DNA-based Vaccine

Indian pharmaceutical company Zydus Cadila is soon going to apply Central Drugs Regulator (DGCI) for emergency approval of the corona vaccine ZyCoV-D. If approved, it will be the world’s first DNA-based vaccine. With this, the number of vaccines available in the country will increase to 4. So far, Serum Institute’s Covishield, Bharat Biotech’s Covaxin and ..

Month: 

Category: 

Topics: 

Summit for Vaccine Internationalism

Four-day Summit for vaccine internationalism by Progressive International was opened on June 18, 2021. Highlights Summit was opened with the goal of ending “covid-19 pandemic as quickly as possible by administering and securing COVID-19 vaccines for all”. Vaccine summit brings together political leaders, Global south governments, healthcare workers and vaccine manufacturers from about twenty countries ..

Month: 

Category: 

Topics: 

AEFI Panel confirms first Death linked to Vaccines

National AEFI (Adverse Events Following Immunisation) panel has confirmed first death linked to covid-19 vaccine. A 68-year-old person got severe allergic reaction after he was vaccinated in March who died later. Key points The panel was set up to study side effects of covid-19 vaccine. Panel confirmed, the first death was due to anaphylaxis (severe ..

Month: 

Category: 

Topics: 

G-7 plans 1 billion extra Covid-19 shots by 2022

Group of Seven (G-7) leaders are set to vow to deliver 1 billion extra doses of vaccines by 2022 to cover 80 percent of world’s adult population. Highlights Ahead of G-7 summit in UK, officials put together document outlining a plan to end pandemic by December 2022. Document is yet to be finalised but it ..

Month: 

Category: 

Topics: 

Antibody Cocktail treatment for Covid

Doctors from Sir Ganga Ram Hospital in New Delhi have successfully analysed the monoclonal antibody therapy on two Covid-19 patients. This therapy resulted into fast progression of symptoms within first seven days. About the therapy Two patients were administered REGCov2 (Casirivimab and Imdevimab). They started to produce resistance against SARS-CoV-2, recovered and then discharged within ..

Month: 

Category: 

Topics: